Incidence of COVID-19 in patients exposed to chloroquine and hydroxychloroquine: results from a population-based prospective cohort in Catalonia, Spain, 2020
Vivanco-Hidalgo, Rosa Maria
Velasco Muñoz, César
Real World Data Working Group
MetadataShow full item record
Background: Several clinical trials have assessed the protective potential of chloroquine and hydroxychloroquine. Chronic exposure to such drugs might lower the risk of infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) or severe coronavirus disease (COVID-19). Aim: To assess COVID-19 incidence and risk of hospitalisation in a cohort of patients chronically taking chloroquine/hydroxychloroquine. Methods: We used linked health administration databases to follow a cohort of patients with chronic prescription of hydroxychloroquine/chloroquine and a control cohort matched by age, sex and primary care service area, between 1 January and 30 April 2020. COVID-19 cases were identified using International Classification of Diseases 10 codes. Results: We analysed a cohort of 6,746 patients (80% female) with active prescriptions for hydroxychloroquine/chloroquine, and 13,492 controls. During follow-up, there were 97 (1.4%) COVID-19 cases in the exposed cohort and 183 (1.4%) among controls. The incidence rate was very similar between the two groups (12.05 vs 11.35 cases/100,000 person-days). The exposed cohort was not at lower risk of infection compared with controls (hazard ratio (HR): 1.08; 95% confidence interval (CI): 0.83–1.44; p=0.50). Forty cases (0.6%) were admitted to hospital in the exposed cohort and 50 (0.4%) in the control cohort, suggesting a higher hospitalisation rate in the former, though differences were not confirmed after adjustment (HR: 1·46; 95% CI: 0.91–2.34; p=0.10). Conclusions: Patients chronically exposed to chloroquine/hydroxychloroquine did not differ in risk of COVID-19 nor hospitalisation, compared with controls. As controls were mainly female, findings might not be generalisable to a male population.
Is part ofEurosurveillance, 2021, vol. 26, num. 9, p. 2001202
European research projects
The following license files are associated with this item:
Except where otherwise noted, this item's license is described as cc-by (c) Vivanco-Hidalgo et al., 2021
Showing items related by title, author, creator and subject.
Incidence of Melanoma in Catalonia, Spain, Is Rapidly Increasing in the Elderly Population. A Multicentric Cohort Study. Podlipnik, Sebastian; Carrera, Cristina; Boada, Aram; Richarz, Nina; Marcoval, Joaquim; Ferreres, Josep Ramón; Bodet, Domingo; Martí Laborda, Rosa Ma.; Segura, Sonia; Sabat, Mireia; Dalmau, Joan; Quintana, Mònica; Azon, Antoni; Curcó, Neus; Formigon, Manel; Olivella-Garcés, María Rosa; Zaballos, Pedro; Sola, Joaquim; Galvany, Loida; Baliu-Piqué, Carola; Alegre, Marta; Pasquali, Paola; Malvehy, Josep; Puig, Susana (MDPI, 2020)The incidence of melanoma has been increasing worldwide during recent decades. The objective of the study was to analyse the trends in incidence for in situ and invasive melanoma in the Spanish region of Catalonia during ...
Lack of protective effect of chloroquine derivatives on COVID-19 disease in a Spanish sample of chronically treated patients Laplana Lafaja, Marina; Yuguero Torres, Oriol; Fibla Palazón, Joan (2020)Background The search for a SARS-CoV-2 treatment has emerged as a worldwide priority. We evaluated the role of chloroquine and its derivatives in COVID-19 in Spanish individuals. Methods We performed a survey addressed ...
Lack of protective effect of chloroquine derivatives on COVID-19 disease in a Spanish sample of chronically treated patients Laplana Lafaja, Marina; Yuguero Torres, Oriol; Fibla Palazón, Joan (Public Library of Science, 2020)Background The search for a SARS-CoV-2 treatment has emerged as a worldwide priority. We evaluated the role of chloroquine and its derivatives in COVID-19 in Spanish individuals. Methods We performed a survey addressed ...